Diseases : DID47685 - Allergy

ZScoreRScoreEntity TypeIDNameSynonyms
1.23573287607 35 - [0, 0, 1, 2] Diseases DID47685 Allergy Allergy; Hypersensitivity reaction type i disease; Hypersensitivity
Back to View Results

RScore Document Snippets Details
25 - [0, 0, 1, 0] Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy.
[MEDLINE : 25445825]
(2015) Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. The Journal of allergy and clinical immunology;J. Allergy Clin. Immunol.;2015 Feb;135(2):370-8

- Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy.

Details
5 - [0, 0, 0, 1] Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils.
[MEDLINE : 30445053]
(2019) Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils. Toxicology;Toxicology;2019 01;411:93-100

- Our findings indicate that ERα and ERβ are involved in the proinflammatory response in respiratory allergy, and their effects may be mediated by an increase in the expression of IL-33 and infiltration of eosinophils.

Details
5 - [0, 0, 0, 1] Hypersensitivity to diethylstilbestrol. Cross-sensitization to dienestrol, hexestrol, bisphenol A, p-benzyl-phenol, hydroquinone-monobenzylether, and p-hydroxybenzoic-benzylester.
[MEDLINE : 13701662]
FREGERT,S,S, RORSMAN,H,H (1960) Hypersensitivity to diethylstilbestrol. Cross-sensitization to dienestrol, hexestrol, bisphenol A, p-benzyl-phenol, hydroquinone-monobenzylether, and p-hydroxybenzoic-benzylester. Acta dermato-venereologica;Acta Derm. Venereol.;1960 ;40:206-19

- Hypersensitivity to diethylstilbestrol.

Details
Back to View Results
Legend


This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.